Results 141 to 150 of about 468,837 (288)
Therapeutic JAK Inhibition in Idiopathic Subglottic Stenosis
Three patients with idiopathic subglottic stenosis and rheumatoid arthritis began JAK inhibitor therapy, after which the mean surgical‐free interval between endoscopic dilations rose from 317 to 631 days and the annualized dilation rate fell from 1.24 to 0.38 per patient‐year. Figure 2 shows this as a per‐patient timeline.
Riley M. Larkin +5 more
wiley +1 more source
Exophytic gastrointestinal tumors, including gastrointestinal stromal tumors and leiomyomas, present unique technical challenges due to their predominantly outward growth pattern.
Xingcen Chen +4 more
doaj +1 more source
How I Do It: Nasoseptal Flap for Reconstruction of Isolated Soft Palate Defect
A vascularized nasoseptal flap (NSF) provides a novel transnasal option for repairing soft palatal fistulas when traditional transoral flaps have failed or are unavailable, potentially avoiding the morbidity of regional or free tissue transfer. In the current patient who had an 8 × 6 mm soft palatal fistula, the NSF was harvested from the septum and ...
Vincent M. Desiato +3 more
wiley +1 more source
Invention of the Flexible Fiberoptic Nasopharyngolaryngoscope: Perspectives From the East
The fiberoptic nasopharyngolaryngoscope was developed in 1967 by Drs. Masayuki Sawashima, Hajime Hirose, and Osamu Fujimura at the University of Tokyo's Research Institute of Logopedics and Phoniatrics (RILP), building on Dr. Shigeto Ikeda's 1962 fiberoptic bronchoscope during Japan's postwar surge in technological innovation.
Carolyn J. Khoury +7 more
wiley +1 more source
What Is the Role of Uvulopalatopharyngoplasty in Contemporary Sleep Surgery?
The Laryngoscope, EarlyView.
Thomas M. Kaffenberger +4 more
wiley +1 more source
Nasolabial Flap in Oncologic Oral Cavity Reconstruction: A Systematic Review and Meta‐Analysis
The nasolabial flap provides a reliable local reconstructive option for selected small‐ to oncologic oral cavity defects, with low flap‐related complications and minimal donor‐site morbidity. Outcomes should nevertheless be interpreted according to defect characteristics, flap design, and the predominantly retrospective nature of the available evidence.
Fabio Maglitto +6 more
wiley +1 more source
Pediatric Epiglottopexy: A Scoping Review of Indications, Techniques, Outcomes, and Complications
This scoping review synthesizes the indications, techniques, outcomes, and complications of pediatric epiglottopexy across 24 studies comprising 371 patients from ten countries. Epiglottopexy, most often performed alongside supraglottoplasty, was associated with favorable respiratory and swallowing outcomes, though the evidence base consists ...
Karim Estephan, Mathieu Bergeron
wiley +1 more source
EHR‐Integrated Synoptic Operative Reporting for Head and Neck Oncologic Surgery
EHR‐integrated synoptic operative templates for head and neck oncologic surgery was developed and implemented at a tertiary academic cancer center. Departmental adherence rose from 49% to nearly 80% over 6 months, and 94.5% of reviewed cases met targets for complete, internally consistent documentation. The resulting structured data dictionary provides
Miriam N. Lango +14 more
wiley +1 more source
Approach to Surgical Repair of Nasal Septal Perforation
Nasal septal perforation repair remains technically demanding, with technique selection guided by perforation size, location, etiology, and patient risk factors. Contemporary evidence supports mucosal advancement flaps for small perforations (< 1 cm), bilateral advancement with interposition grafting or trilayer temporoparietal fascia–polydioxanone ...
Nicole J. Reynoso +2 more
wiley +1 more source
Risk of Long‐Term Airway Sequelae and Mortality in Laryngeal Chondrosarcoma
ABSTRACT Objective In low‐ and intermediate‐grade laryngeal chondrosarcomas, nonradical surgery or even debulking is considered justifiable to preserve laryngeal function. However, tumor‐ and treatment‐related factors affecting the need for reoperation and long‐term risk for tracheostomy remain unclear.
Taru Ilmarinen +5 more
wiley +1 more source

